drugset / Trial / NCT02270307
MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis
NaSingle-groupOpen-labelPrevention
Summary
Evaluating the effectiveness of the new protocol which replace the standard immunosuppressive therapy with use of MSCs and CY in patients at high risk of relapse.
Timeline
- Start
- 2014-01
- Primary completion
- 2016-01
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 50 mg/kg | — |
| Subject | mesenchymal stem cells | Cell therapy | 1e+06 cells/kg | — |